SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome. Clinics, [S. l.], v. 77, p. 100064, 2022. DOI: 10.1016/j.clinsp.2022.100064. Disponível em: https://revistas.usp.br/clinics/article/view/213603.. Acesso em: 20 may. 2024.